2023/0307 - EPOETINAS DE MÉDIA DURAÇÃO [µg FRS/AMP/SERINGA]
TED · 359537-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 22 | — | 2026-08-04 |
| GILEAD SCIENCES, LDA | 18 | — | 2026-07-28 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 15 | €1,569,649 | 2026-08-04 |
| NOVARTIS FARMA - PROD.FARM SA | 11 | — | 2026-08-04 |
| JANSSEN-CILAG FARMACEUTICA LDA | 9 | €371,730 | 2026-08-04 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
EPOETINAS DE MÉDIA DURAÇÃO [µg FRS/AMP/SERINGA]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-27 | 2023/0307 - EPOETINAS DE MÉDIA DURAÇÃO [µg FRS/AMP/SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-06-02 | 2023/0671 - RISDIPLAM [60 MG PÓ SOL ORAL FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-06-24 | 2023/0438 - PLASMA HUMANO (ml) | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-05-12 | 2023/0671 - PATISIRAN [2 MG/ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-06-24 | 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-06-30 | 2023/0436 - NUSINERSEN [12 MG/5 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |